Typhoid conjugate vaccine from Indonesia found to be safe, immunogenic in phase 1 clinical trial

    SEOUL, Korea, JAKARTA, Indonesia, February 22, 2019 — Scientists from Bio Farma, the University of Indonesia, and the International Vaccine Institute (IVI), recently published the results of a phase I clinical trial study of a novel typhoid conjugate vaccine involving Indonesian adults and […]

IVI Forum for Enhancement of Cooperation


IVI scientists’ paper recommended by Faculty of 1000 Biology, and Korea’s bioscience portal

Dr. Manki Song, Acting Deputy Director General of Science   Dr. Manki Song, Acting Deputy Director General of Science, Dr. Jae Seung Yang, Senior Scientist, and Ms. Eun Young Lee, Researcher at IVI, and others’ manuscript “Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, […]

Former KSC Vice President Ms. Joanne Lee donates 50 million KRW to IVI

  Ms. Joanne Lee, former Vice President of the Korea Support Committee for IVI and former Chairperson of the IVI Fundraising Campaign Committee (2005-2006), donated 50 million KRW (US$42,000) via KSC to support IVI’s vaccine research and development. Ms. Lee, who is currently based in […]